Stay updated with breaking news from Clinical Implications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sara A. Hurvitz, MD, presents data from the phase 3 HER2CLIMB-02 study investigating tucatinib and trastuzumab emtansine in patients with previously treated HER2+ metastatic breast cancer.
Experts discuss the clinical implications of the MAJIC-PV trial.
Endocrine therapy, particularly when administered in combination with Verzenio (abemaciclib), is effective when compared with chemotherapy among patients with metastatic breast cancer who experienced disease progression on Ibrance (palbociclib), according to recently published research.
The treatment, management and progression of Parkinson’s disease by Theresa Lowry-Lehnen Parkinson’s disease (PD) is a progressive neurodegenerative
Looking for a way to boost energy and performance on your next run? You’ll find the best pre-workout for running on this list 2023.